Israel Englander Millennium Management
Israel “Izzy” Englander is the founder of Millennium Management, one of the world’s largest multi-strategy hedge fund platforms. Millennium allocates capital across hundreds of independent teams rather than a single house view, with rigorous risk controls at the platform level. Englander’s model has been highly influential in the rise of pod-shop multi-manager structures across the industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$593M |
| 2 |
Abbott
ABT
|
+$259M |
| 3 |
AutoZone
AZO
|
+$204M |
| 4 |
AABA
Altaba Inc
AABA
|
+$186M |
| 5 |
D.R. Horton
DHI
|
+$178M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Honeywell
HON
|
+$215M |
| 2 |
Public Service Enterprise Group
PEG
|
+$211M |
| 3 |
Applied Materials
AMAT
|
+$203M |
| 4 |
Intuitive Surgical
ISRG
|
+$194M |
| 5 |
ConocoPhillips
COP
|
+$192M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 14.49% |
| 2 | Technology | 12.13% |
| 3 | Healthcare | 11.89% |
| 4 | Consumer Discretionary | 11.58% |
| 5 | Industrials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PENG
1701
Penguin Solutions Inc
PENG
$2.66B
| $5.49M | 0.01% |
325,534
+304,736
| +1,465% | +$4.83M |
|
1702
Tilly's
TLYS
$120M
| $5.47M | 0.01% |
370,804
+245,115
| +195% | +$3.29M |
|
1703
Dine Brands
DIN
$446M
| $5.45M | 0.01% |
107,341
-5,123
| -5% | -$239K |
|
1704
Telkom Indonesia
TLK
$14.5B
| $5.44M | 0.01% |
168,727
+158,216
| +1,505% | +$4.95M |
|
1705
Capri Holdings
CPRI
$1.55B
| $5.42M | 0.01% |
86,163
+73,630
| +587% | +$4.04M |
|
1706
PUT
Kohl's
KSS
$2.03B
| $5.42M | 0.01% |
+100,000
| New | +$4.6M |
|
|
HSII
1707
DELISTED
Heidrick & Struggles
HSII
| $5.41M | 0.01% |
220,421
+150,127
| +214% | +$3.52M |
|
|
GNC
1708
DELISTED
GNC Holdings, Inc.
GNC
| $5.41M | 0.01% |
1,465,258
+1,409,237
| +2,516% | +$8.86M |
|
|
BIVV
1709
CALL
DELISTED
Bioverativ Inc. Common Stock
BIVV
| $5.39M | 0.01% |
+100,000
| New | +$5.47M |
|
|
ADAP
1710
DELISTED
Adaptimmune Therapeutics
ADAP
| $5.38M | 0.01% |
805,595
+215,439
| +37% | +$1.66M |
|
1711
Visteon
VC
$2.77B
| $5.37M | 0.01% |
42,927
+16,515
| +63% | +$2.09M |
|
1712
CALL
Celanese
CE
$4.91B
| $5.35M | 0.01% |
50,000
+7,500
| +18% | +$797K |
|
|
CLR
1713
PUT
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $5.3M | 0.01% |
+100,000
| New | +$4.39M |
|
|
LTRPA
1714
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
| $5.3M | 0.01% |
561,888
+284,369
| +102% | +$2.92M |
|
|
PRTK
1715
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
| $5.29M | 0.01% |
295,622
-38,731
| -12% | -$808K |
|
|
PVLA
1716
Palvella Therapeutics
PVLA
$2.22B
| $5.28M | 0.01% |
8,747
+3,208
| +58% | +$1.49M |
|
1717
CALL
Colgate-Palmolive
CL
$73.4B
| $5.28M | 0.01% |
70,000
-130,000
| -65% | -$9.49M |
|
1718
FirstService
FSV
$6.27B
| $5.25M | 0.01% |
75,162
+47,684
| +174% | +$3.28M |
|
|
AZPN
1719
DELISTED
ASPEN TECHNOLOGY INC
AZPN
| $5.25M | 0.01% |
79,253
-289,500
| -79% | -$19.2M |
|
|
SINA
1720
DELISTED
Sina Corp
SINA
| $5.25M | 0.01% |
52,287
-145,474
| -74% | -$15.5M |
|
1721
Monarch Casino & Resort
MCRI
$2.23B
| $5.24M | 0.01% |
116,937
+81,798
| +233% | +$3.63M |
|
1722
Bank of Marin Bancorp
BMRC
$434M
| $5.23M | 0.01% |
153,924
+96,872
| +170% | +$3.34M |
|
1723
AMERISAFE
AMSF
$487M
| $5.21M | 0.01% |
84,624
+43,937
| +108% | +$2.76M |
|
1724
ArcBest
ARCB
$3.11B
| $5.21M | 0.01% |
145,821
+49,894
| +52% | +$1.7M |
|
1725
Iovance Biotherapeutics
IOVA
$3.66B
| $5.2M | 0.01% |
649,651
-1,431,829
| -69% | -$11.5M |
|
Similar funds
Israel Englander's Q4 2017 Portfolio in Review
As of Q4 2017, Israel Englander held 4,357 positions worth $72.5B, up 10% from $65.6B the previous quarter. Its ten largest holdings account for 6.7% of the portfolio.
Israel Englander deployed $3.05B of net new capital in Q4 2017, opening 897 new positions and adding to 1,473 existing holdings. Its largest new stake was Viatris: 2,905,317 shares worth $123M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 14% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Honeywell, an estimated $215M trimmed.
- Israel Englander's largest Q4 2017 buy was Viatris: 2,905,317 shares worth $123M.
- Israel Englander added most to State Street SPDR S&P 500 ETF Trust in Q4 2017, an estimated $593M increase.
- Israel Englander's biggest Q4 2017 reduction was Honeywell, cutting an estimated $215M.
- Israel Englander fully exited Paychex in Q4 2017, selling an estimated $66.4M.
- Israel Englander's ten largest holdings make up 6.7% of its $72.5B portfolio in Q4 2017.
- Israel Englander opened 897 new positions and closed 601 in Q4 2017.
- Israel Englander's portfolio value rose 10% quarter-over-quarter to $72.5B.
Based on Millennium Management's 13F filing for Q4 2017, filed 14 Feb 2018.